JC, S., HE, T., NM, P., R, V., C, A. Z., TR, S., . . . MO, B. (2025). Effect of caffeine and cannabidiol (CBD) co-administration on Δ9-tetrahydrocannabinol (Δ9-THC) subjective effects, performance impairment, and pharmacokinetics. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 50(12), 1827. https://doi.org/10.1038/s41386-025-02232-x
Chicago Style (17th ed.) CitationJC, Strickland, et al. "Effect of Caffeine and Cannabidiol (CBD) Co-administration on Δ9-tetrahydrocannabinol (Δ9-THC) Subjective Effects, Performance Impairment, and Pharmacokinetics." Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology 50, no. 12 (2025): 1827. https://doi.org/10.1038/s41386-025-02232-x.
MLA (9th ed.) CitationJC, Strickland, et al. "Effect of Caffeine and Cannabidiol (CBD) Co-administration on Δ9-tetrahydrocannabinol (Δ9-THC) Subjective Effects, Performance Impairment, and Pharmacokinetics." Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, vol. 50, no. 12, 2025, p. 1827, https://doi.org/10.1038/s41386-025-02232-x.